威爾遜重申對Clarity Pharmaceuticals Ltd. (CU6)的買入評級。
威爾遜堅持爲Clarity Pharmaceuticals Ltd. (CU6) 維持買入評級。
Jefferies將Clarity Pharmaceuticals的目標股價上調11%至A$8.20/每股分享
貝爾波特獲得買入評級:Clarity Pharmaceuticals Ltd.(CU6)
Clarity Pharmaceuticals的目標股價由Bell Potter從A $4.00上調至A $10.00/Share
Jefferies堅持對Clarity Pharmaceuticals Ltd. (CU6)的買入評級。
暫無數據